Ppt for in-vitro colorectal cancer screening tests market: Global Market Insights,Inc.

1
In-vitro Colorectal Cancer Screening Tests Market
2016 2023
2
Global Market Scenario of In-vitro Colorectal
Cancer Screening Tests

• In-Vitro Colorectal Cancer Screening Tests
  Market size was USD 599.8 million in 2015, with
  growth forecast at 5.3 CAGR from 2016 to 2023.
• Growing incidences of colon and rectal cancer and
  the introduction of novel cancer screening tests
  using genetic testing will continue to be a
  critical driving factor for the global in-vitro
  colorectal cancer screening tests market over the
  forecast timeline.
• Colorectal cancer is the third most commonly
  diagnosed cancer, and the number of deaths due to
  colorectal cancer has been on rise over the past
  few years.
• According to estimates by, the American Cancer
  Society and GLOBOCAN, colorectal cancer has
  remained the second or third most common cause
  for cancer related deaths worldwide. This has led
  to a growing concern among the people and
  government.
• https//www.gminsights.com/industry-analysis/in-vi
  tro-colorectal-cancer-screening-tests-market

3
Continue.....

• Growing concern regarding the early diagnosis of
  colorectal cancer has led to government
  initiatives aimed at keeping colorectal cancer
  under check. 
• The American and European agencies have issued
  guidelines for the regular screening of
  colorectal screening and risk levels of diagnosis
  of colorectal cancer.
• Such CRC screening initiatives undertaken by the
  governments has led to implementation of mass CRC
  screening programs, leading to increase in demand
  for these tests.
• The need for minimally invasive and high accuracy
  cancer screening tests has led to increasing
  investments for research and development of
  genetic screening tests for colorectal cancer.
• Genetic cancer screening tests make use of DNA
  testing and biomarker analysis to estimate the
  presence or risk levels of colorectal cancer
  offering high accuracy.
• https//www.gminsights.com/industry-analysis/in-vi
  tro-colorectal-cancer-screening-tests-market

4
U.S. In-vitro colorectal cancer screening tests
market size, by test type, 2012 - 2023 (USD
Million)

https//www.gminsights.com/industry-analysis/in-vi
tro-colorectal-cancer-screening-tests-market
5
360 Analysis

• Application Analysis
• Fecal occult blood tests dominated the in-vitro
  colorectal cancer screening tests market size by
  revenue, at more than USD 230 million in 2015.
  Growing incidence of colorectal cancer leading to
  high usage rate, and ease of use for screening
  large group of population has been instrumental
  in strengthening the demand for fecal occult
  blood tests.  
• Regional Analysis
• North America remains the largest regional
  industry, owing to significant revenue outlay in
  the U.S., with target revenue of more than USD
  400 million by 2023.
• Europe shows high colorectal cancer prevalence.
  The European Commission has launched a three year
  Joint Action on cancer control in 2014, to give
  continuity to the efforts to improve cancer
  control by raising quality standards of screening
  tests, funded from 2nd EU Health Programme.
  Europe in-vitro colorectal cancer screening tests
  market share is projected to reach USD 300.6
  million by 2023.  
• Competitive Market Share
• Global in-vitro colorectal cancer screening tests
  market share is highly competitive and marked by
  frequent mergers and acquisitions, strategic
  alliances, collaborations to widen product
  portfolio. Some of the dominant players include
  Abbott Molecular, Alere, Beckman Coulter, Eiken
  Chemical, and Siemens Healthcare.  

6

Latest Research Report On In-Vitro Colorectal
Cancer Screening Tests Market _at_
https//www.gminsights.com/industry-analysis/in-vi
tro-colorectal-cancer-screening-tests-market
Download Latest Report PDF _at_
https//www.gminsights.com/request-sample/detail/4
51
7
Stay In Touch You can visit us at
www.gminsights.com